orexigen therapeutics inc
(OREX:Consolidated Issue Listed on NASDAQ Global Select )
Preston S. Klassen M.D., M.H.S.
Head of Global Development and Executive Vice President, Orexigen Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Preston S. Klassen, M.D., M.H.S., has been an Executive Vice President and Head of Global Development at Orexigen Therapeutics, Inc. since February 2015 and served as its Senior Vice President of Product Development and Head of Global Contrave Program since November 2009. Dr. Klassen served as Head of Global Development and Senior Vice President at Orexigen Therapeutics, Inc. Dr. Klassen led the global development program for Contrave. Formerly the Therapeutic ...
3344 North Torrey Pines CourtPhone: 858-875-8600
La Jolla, California 92037
Board Members Memberships*
Independent Director and Member of Nominating & Corporate Governance Committee
University of Nebraska College of Medicine
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer|
Arena Pharmaceuticals, Inc.
|Seth H. Z. Fischer||Chief Executive Officer, Chief Commercial Officer and Director|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Lars Rebien Sørensen||Chief Executive Officer, President and Member of Executive Management|
Novo Nordisk A/S
|kr15.2M||Compensation as of Fiscal Year 2014.|